Funakoshi Kei

Research theme for competitive and other funds (3)：

2008 - 2009 ldentification of new target moJecule in autoimmune-mediated polyneuropathy and establ ishment of a disease model
2006 - 2007 Fisher症候群モデル動物の樹立
2005 - 2006 1次感覚ニューロンにおけるb系列ガングリオシドの機能的役割

Papers (31)：

Suzuki Keisuke, Suzuki Shiho, Shiina Tomohiko, Haruyama Yasuo, Fujita Hiroaki, Funakoshi Kei, Hirata Koichi. Could efficacy at 1 week after galcanezumab administration for patients with migraine predict responders at 3 months? A real world study. Journal of neurology. 2023
Funakoshi Kei, Suzuki Keisuke. A safe change from eculizumab to satralizumab in a patient with neuromyelitis optica spectrum disorder. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2022. 44. 3. 1097-1098
Komagamine Tomoko, Suzuki Keisuke, Kokubun Norito, Komagamine Junpei, Kawasaki Akiko, Funakoshi Kei, Hirata Koichi. Sleep-related hallucinations in patients with Parkinson's disease. PloS one. 2022. 17. 10. e0276736
Watanabe Shohei, Tokuhara Yusuke, Hiratsuka Mari, Yoshizumi Kazuki, Ukon Shinichiro, Kasama Shuhei, Takeda Masanaka, Funakoshi Kei, Kimura Takashi. Additional Steroid Therapy for Delayed Facial Palsy in Miller Fisher Syndrome. Internal medicine (Tokyo, Japan). 2022. 61. 22. 3435-3438
Suzuki Keisuke, Funakoshi Kei, Fujita Hiroaki, Hirata Koichi. The Effect of Rotigotine on Cognitive Function, Daytime Sleepiness, and Sleep Problems in Parkinson Disease: An Open-Label Pilot Study. Clinical neuropharmacology. 2022. 45. 3. 61-64

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page